Key result
Fluoroquinolones carry a small overall risk of QT prolongation and Torsades de pointes, with moxifloxacin having the greatest risk and ciprofloxacin the lowest.
Why the study?
Do fluoroquinolones increase the risk of QT prolongation and Torsade de Pointes?
Do fluoroquinolones increase the risk of QT prolongation and Torsade de Pointes?
Fluoroquinolones carry a small overall risk of QT prolongation and Torsade de Pointes, with moxifloxacin having the highest risk and ciprofloxacin the lowest.
No takes yet. Share an insight, caveat, or question.
Supports preferring ciprofloxacin over moxifloxacin when QT risk is a concern; leaves open need for randomized confirmation.
Briasoulis et al. (2011) conducted a review in QT prolongation and Torsades de pointes. Fluoroquinolones was evaluated on QT prolongation and Torsades de pointes. Fluoroquinolones carry a small overall risk of QT prolongation and Torsades de pointes, with moxifloxacin having the greatest risk and ciprofloxacin the lowest.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: